Class IB-phosphatidylinositol 3-kinase (PI3K) deficiency ameliorates IA-PI3K-induced systemic lupus but not T cell invasion

被引:62
作者
Barber, DF
Bartolomé, A
Hernandez, C
Flores, JM
Fernandez-Arias, C
Rodríguez-Borlado, L
Hirsch, E
Wymann, M
Balomenos, D
Carrera, AC
机构
[1] Univ Autonoma Madrid, Dept Immunol & Oncol, E-28049 Madrid, Spain
[2] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Anim Facil, E-28049 Madrid, Spain
[3] Univ Complutense Madrid, Sch Vet, Dept Anim Med & Surg, E-28040 Madrid, Spain
[4] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy
[5] Univ Fribourg, Inst Biochem, CH-1700 Fribourg, Switzerland
关键词
D O I
10.4049/jimmunol.176.1.589
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Class I PI3K catalyzes formation of 3-poly-phosphoinositides. The family is divided into I-A isoforms, activated by Tyr kinases and I-A the I-B isoform (PI3K gamma), activated by G protein-coupled receptors. Mutations that affect PI3K are implicated in chronic inflammation, although the differential contribution of each isoform to pathology has not been elucidated. Enhanced activation of class I-A-PI3K in T cells extends CD4(+) memory cell survival, triggering an invasive lymphoproliferative disorder and systemic lupus. As both I-A- and 1(B)-PI3K isoforms regulate T cell activation, and activated pathogenic CD4(+) memory cells are involved in triggering systemic lupus, we examined whether deletion of I-B could reduce the pathological consequences of increased I-A-PI3K activity. I-B-PI3K gamma deficiency did not abolish invasion or lymphoproliferation, but reduced CD4(+) memory cell survival, autoantibody production, glomerulonephritis, and systemic lupus. Deletion of the I-B-PI3K gamma isoform thus decreased survival of pathogenic CD4(+) memory cells, selectively inhibiting systemic lupus development. These results validate the PI3K gamma isoform as a target for systemic lupus erythernatosus treatment.
引用
收藏
页码:589 / 593
页数:5
相关论文
共 24 条
[1]   PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus [J].
Barber, DF ;
Bartolomé, A ;
Hernandez, C ;
Flores, JM ;
Redondo, C ;
Fernandez-Arias, C ;
Camps, M ;
Ruckle, T ;
Schwarz, MK ;
Rodríguez, S ;
Martinez-A, C ;
Balomenos, D ;
Rommel, C ;
Carrera, AC .
NATURE MEDICINE, 2005, 11 (09) :933-935
[2]  
BERDEN JHM, 1983, J IMMUNOL, V130, P1699
[3]   Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Wynshaw-Boris, A ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10963-10968
[4]   Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Nussbaum, RL .
MAMMALIAN GENOME, 2002, 13 (03) :169-172
[5]  
Borlado LR, 2000, FASEB J, V14, P895
[6]   New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase AKT pathway [J].
Cantley, LC ;
Neel, BG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4240-4245
[7]   Impaired Fas response and autoimmunity in Pten+/- mice [J].
Di Cristofano, A ;
Kotsi, P ;
Peng, YF ;
Cordon-Cardo, C ;
Elkon, KB ;
Pandolfi, PP .
SCIENCE, 1999, 285 (5436) :2122-2125
[8]   Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling [J].
Fruman, DA .
CURRENT OPINION IN IMMUNOLOGY, 2004, 16 (03) :314-320
[9]   Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation [J].
Hirsch, E ;
Katanaev, VL ;
Garlanda, C ;
Azzolino, O ;
Pirola, L ;
Silengo, L ;
Sozzani, S ;
Mantovani, A ;
Altruda, F ;
Wymann, MP .
SCIENCE, 2000, 287 (5455) :1049-1053
[10]  
KLINMAN DM, 1995, IMMUNOL REV, V144, P157